NABP NAPLEX Exam - Topic 8 Question 53 Discussion

Actual exam question for NABP's NAPLEX exam

Question #: 53
Topic #: 8

[All NAPLEX Questions]

Which of the following beta-blocker is NOT proven to reduce mortality in patients with Systolic CHF?

ABisoprolol

BNadolol

CCarvedilol

DMetoprolol succinate

EMetoprolol Tartrate

Show Suggested Answer

Suggested Answer: E

Nadolol is not proven to reduce mortality in patients with systolic CHF. The efficacy of nadolol in HF has not been determined. For patients taking nadolol, it should be used with caution in those with compensated heart failure and patients should be monitored for a worsening of the condition. Bisoprolol, carvedilol, and sustained- release metoprolol succinate are the beta-blockers that have been proven to reduce mortality in patients with systolic CHF. These 3 beta-blockers have been effective in reducing the risk of death in patients with chronic HFrEF. Other beta-blockers were found to be less effective. Bucindolol did not exhibit uniform effectiveness across different populations. Metoprolol tartrate was found to be less effective in HF clinical trials.

http://circ.ahajournals.org/content/128/16/e240

by Bette at Oct 11, 2022, 02:54 AM

Limited Time Offer

25%

Off

Get Premium NAPLEX Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

Submit Cancel

Stephen

4 months ago

Wait, are you sure about that? I always thought they were similar!

upvoted 0 times

...

Peter

4 months ago

Totally agree, Metoprolol Tartrate is the odd one out here.

upvoted 0 times

...

Celestina

4 months ago

Nadolol is also not great for CHF.

upvoted 0 times

...

Devorah

4 months ago

I thought Metoprolol succinate was the one that helps!

upvoted 0 times

...

Celestina

4 months ago

Metoprolol Tartrate isn't proven to reduce mortality in CHF.

upvoted 0 times

...

Fernanda

5 months ago

I’m leaning towards Metoprolol tartrate as the answer since I remember it being mentioned as less effective compared to the others in class.

upvoted 0 times

...

Ma

5 months ago

I’m a bit confused about Nadolol and Metoprolol tartrate. I know they both are beta-blockers, but I can't recall which one is not proven for CHF.

upvoted 0 times

...

Julieta

5 months ago

I think Metoprolol tartrate is the one that doesn't have strong evidence for mortality reduction. It feels like I saw a similar question in practice.

upvoted 0 times

...

Otis

5 months ago

I remember studying that Bisoprolol, Carvedilol, and Metoprolol succinate are all proven to reduce mortality in CHF, but I'm not sure about Nadolol.

upvoted 0 times

...

Meaghan

5 months ago

I'm pretty confident this is a straightforward question. I think the answer is B - Landing Page Editor > Change URL.

upvoted 0 times

...

Yesenia

5 months ago

I'm pretty confident that DMS is correct, but I can't recall whether it was Data Works or QuickBl for the other one.

upvoted 0 times

...

Gearldine

5 months ago

Okay, I've got this. The key here is that the question is asking about optimizing the placement of advertising banners based on the app's business and user needs. That sounds like a UX designer's responsibility to me. I'll go with option B.

upvoted 0 times

...

Glory

5 months ago

Okay, I've got this. The most critical thing is maintaining the chain of custody, so I'm going with option C. Gotta make sure there's a documented log of who accessed the workstations.

upvoted 0 times

...

Alison

5 months ago

I've got this! The equity is the credit balance ($42,000) minus the short market value ($22,000), plus the SMA ($500). So the total equity is $42,000 - $22,000 + $500 = $20,500.

upvoted 0 times

...